The Associations between Liver Enzymes and Cardiovascular Risk Factors in Adults with Mild Dyslipidemia

Eun-Ock Park1, Eun Ju Bae2, Byung-Hyun Park3

  • 1Clinical Trial Center for Functional Foods, Chonbuk National University Hospital, Jeonju 54907, Jeonbuk, Korea.

Insights

Elevated liver enzymes like gamma-glutamyltransferase (GGT) are linked to increased cardiovascular disease (CVD) risk in individuals with mild dyslipidemia. Routine GGT screening can aid early CVD detection in these patients.

Area of Science:

  • Cardiology
  • Hepatology
  • Clinical Biochemistry

Background:

  • Hypertension and dyslipidemia are significant cardiovascular disease (CVD) risk factors.
  • Abnormal liver function tests may indicate heightened CVD risk, even with mild dyslipidemia.

Purpose of the Study:

  • To investigate the relationship between liver enzymes and cardiovascular risk factors in patients with mild dyslipidemia.
  • To determine if liver enzymes can predict cardiovascular risk in this population.

Main Methods:

  • Analysis of 438 participants from nine clinical studies (2009-2019) at Chonbuk National University Hospital.
  • Assessment of trends in blood pressure and cardiovascular risk factors across quartiles of serum liver enzymes (GGT, ALT, AST, ALP).
  • Multivariate logistic regression analysis to determine odds ratios for hypertension adjusted for lifestyle factors.

Main Results:

  • Significant linear increases in blood pressure and cardiovascular risk factors were observed with rising GGT and ALT levels.
  • Hypertension prevalence increased across GGT and ALT quartiles.
  • Highest GGT quartile showed a 3.688 odds ratio for hypertension, indicating GGT as a strong predictor.

Conclusions:

  • Gamma-glutamyltransferase (GGT) is a superior marker for predicting CVD risk among liver enzymes in patients with mild dyslipidemia.
  • Routine plasma GGT screening can facilitate early CVD detection in individuals with mild dyslipidemia.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
504
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.7K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
662
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
120